[English] 日本語

- PDB-8z4e: Structure of human 18_14D scFv and 1G01 scFv in complex with infl... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 8z4e | ||||||
---|---|---|---|---|---|---|---|
Title | Structure of human 18_14D scFv and 1G01 scFv in complex with influenza virus neuraminidase from A/Yunan/DQ001/2016 (H5N6) | ||||||
![]() |
| ||||||
![]() | VIRAL PROTEIN / influenza virus / neuraminidase / human monoclonal antibody / immunogen | ||||||
Function / homology | ![]() exo-alpha-sialidase / exo-alpha-sialidase activity / viral budding from plasma membrane / carbohydrate metabolic process / host cell plasma membrane / virion membrane / metal ion binding / membrane Similarity search - Function | ||||||
Biological species | ![]() ![]() ![]() | ||||||
Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3 Å | ||||||
![]() | Wang, M. / Peng, Q. / Gao, Y. / Shi, Y. | ||||||
Funding support | ![]()
| ||||||
![]() | ![]() Title: A human monoclonal antibody targeting the monomeric N6 neuraminidase confers protection against avian H5N6 influenza virus infection. Authors: Min Wang / Yuan Gao / Chenguang Shen / Wei Yang / Qi Peng / Jinlong Cheng / Han-Ming Shen / Yang Yang / George Fu Gao / Yi Shi / ![]() Abstract: The influenza neuraminidase (NA) is a potential target for the development of a next-generation influenza vaccine, but its antigenicity is not well understood. Here, we isolate an anti-N6 human ...The influenza neuraminidase (NA) is a potential target for the development of a next-generation influenza vaccine, but its antigenicity is not well understood. Here, we isolate an anti-N6 human monoclonal antibody, named 18_14D, from an H5N6 avian influenza virus (AIV) infected patient. The antibody weakly inhibits enzymatic activity but confers protection in female mice, mainly via ADCC function. The cryo-EM structure shows that 18_14D binds to a unique epitope on the lateral surface of the N6 tetramer, preventing the formation of tightly closed NA tetramers. These findings contribute to the molecular understanding of protective immune responses to NA of AIVs in humans and open an avenue for the rational design of NA-based vaccines. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 164.3 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 120.9 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Arichive directory | ![]() ![]() | HTTPS FTP |
---|
-Related structure data
Related structure data | ![]() 39762MC M: map data used to model this data C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
-
Assembly
Deposited unit | ![]()
|
---|---|
1 |
|
-
Components
-Antibody , 4 types, 4 molecules BCEF
#2: Antibody | Mass: 22813.119 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: According to author, Entity 2 (Light chain of 18_14D scFV, 216 aa, chain B) and Entity 3 (Heavy chain of 18_14D scFV, 236 aa, chain C) are not expressed as one chain. Source: (gene. exp.) ![]() ![]() |
---|---|
#3: Antibody | Mass: 25064.055 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() |
#4: Antibody | Mass: 24933.908 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: According to author, Entity 4 (Heavy chain of 1G01 scFv, 232 aa, chain E) and Entity 5 (Light chain of 1G01 scFV, 216 aa, chain F) are not expressed as one chain. Source: (gene. exp.) ![]() ![]() |
#5: Antibody | Mass: 23677.273 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() |
-Protein / Sugars / Non-polymers , 3 types, 3 molecules A

#1: Protein | Mass: 42155.621 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: Sequence reference for Influenza A virus (A/Yunan/DQ001/2016 (H5N6)) is not available at the time of biocuration. Current sequence reference is from UniProt ID A0A0K0YAP8. Source: (gene. exp.) ![]() ![]() ![]() |
---|---|
#6: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source |
#7: Chemical | ChemComp-CA / |
-Details
Has ligand of interest | Y |
---|---|
Has protein modification | Y |
-Experimental details
-Experiment
Experiment | Method: ELECTRON MICROSCOPY |
---|---|
EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
Component | Name: Structure of human 18_14D C and 1G01 scFv in complex with influenza virus neuraminidase from A/Yunan/DQ001/2016 (H5N6) Type: COMPLEX / Entity ID: #1-#5 / Source: RECOMBINANT |
---|---|
Source (natural) | Organism: ![]() ![]() |
Source (recombinant) | Organism: ![]() |
Buffer solution | pH: 7.5 |
Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
Vitrification | Cryogen name: ETHANE |
-
Electron microscopy imaging
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
---|---|
Microscopy | Model: FEI TITAN KRIOS |
Electron gun | Electron source: ![]() |
Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 2000 nm / Nominal defocus min: 1000 nm |
Image recording | Electron dose: 60 e/Å2 / Film or detector model: GATAN K2 BASE (4k x 4k) |
-
Processing
CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION |
---|---|
3D reconstruction | Resolution: 3 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 116206 / Symmetry type: POINT |